KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration
Watanabe, Yusuke, Murata, Takahiko, Amakawa, Masahiro, Miyake, Yoshihide, Handa, Tango, Konishi, Katsuhiko, Matsumura, Yasushi, Tanaka, Takuji, Takeuchi, KojiVolume:
754
Language:
english
Journal:
European Journal of Pharmacology
DOI:
10.1016/j.ejphar.2015.02.021
Date:
May, 2015
File:
PDF, 7.19 MB
english, 2015